No Data
No Data
Press Release: Eupraxia Pharmaceuticals Announces Voting Results From Annual General and Special Meeting of Shareholders
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders PR Newswire VICTORIA, BC, June 6, 2024 VICTORIA, BC, June 6, 2024 /PRNewswire/ - Eupraxia P
Eupraxia Pharmaceuticals to Present Data From the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
VICTORIA, BC, June 5, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage...
Eupraxia Says Regulators In Australia And Canada Have Cleared Request To Expand Its Phase 1b/2a Resolve Trial
Eupraxia Says Regulators In Australia And Canada Have Cleared Request To Expand Its Phase 1b/2a Resolve Trial
Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
Eight of nine patients responding to the treatment, plus the encouraging safety data observed in the RESOLVE Phase 1b/2a trial of EP-104GI, provided...
Sector Update: Health Care Stocks Lower Premarket Wednesday
Health care stocks were lower premarket Wednesday as the iShares Biotechnology ETF (IBB) was 0.5% lower and the Health Care Select Sector SPDR Fund (XLV) was down 0.3% recently. Eupraxia Pharmaceutica
Sector Update: Health Care
Health care stocks were flat to lower premarket Wednesday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. Eupraxia Pharmaceuticals (EPRX
No Data